PRO-CTCAE Analysis of Mobocertinib in EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Garcia Campelo, M. R. [1 ]
Zhou, C. [2 ]
Ramalingam, S. S. [3 ]
Lin, H. M. [4 ]
Kim, T. M. [5 ]
Riely, G. J. [6 ]
Mekhail, T. [7 ]
Nguyen, D. [8 ]
Biber, J. [9 ]
Romero, H. [4 ]
Goodman, E. [4 ]
Popat, S. [10 ,11 ]
Janne, P. A. [12 ]
机构：
[1] Complejo Hosp Univ A Coruna, La Coruna, Spain
[2] Shanghai Pulm Hosp, Shanghai, Peoples R China
[3] Emory Univ, Atlanta, GA USA
[4] Takeda Dev Ctr Amer Inc, Lexington, MA USA
[5] Seoul Natl Univ Hosp, Seoul, South Korea
[6] Mem Sloan Kettering Canc Ctr, New York, NY USA
[7] AdventHealth, Orlando, FL USA
[8] City Hope Natl Med Ctr, Los Angeles, CA USA
[9] Xcenda LLC, Carrollton, TX USA
[10] Royal Marsden Hosp, London, England
[11] Inst Canc Res, London, England
[12] Dana Farber Canc Inst, Boston, MA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
non-small cell lung cancer; exon20; insertion; patient-reported outcomes;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-17
引用
收藏
页码：S487 / S488
页数：2
相关论文
共 50 条
  • [31] Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations
    Christopoulos, Petros
    Prawitz, Thibaud
    Hong, Jin-Liern
    Lin, Huamao M.
    Hernandez, Luis
    Jin, Shu
    Tan, Min
    Proskorovsky, Irina
    Lin, Jianchang
    Zhang, Pingkuan
    Patel, Jyoti D.
    Ou, Sai-Hong I.
    Thomas, Michael
    Stenzinger, Albrecht
    LUNG CANCER, 2023, 179
  • [32] Osimertinib Treatment for Patients with EGFR exon 20 Insertion Positive Non-Small-Cell Lung Cancer
    Van Veggel, B.
    Van der Wekken, A.
    Hashemi, S.
    Cornelissen, R.
    Monkhorst, K.
    Heideman, D.
    Radonic, T.
    Schuuring, E.
    Smit, E.
    De Langen, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S815 - S815
  • [33] Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation
    Prelaj, Arsela
    Bottiglieri, Achille
    Bhat, Gajanan
    Washington, Rocky
    Calareso, Giuseppina
    Greco, Gabriella Francesca
    Ferrara, Roberto
    Brambilla, Marta
    De Toma, Alessandro
    Occhipinti, Mario
    Manglaviti, Sara
    Soro, Alberto
    Ganzinelli, Monica
    Lo Russo, Giuseppe
    Proto, Claudia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer
    van Veggel, B.
    Santos, J. F. Vilacha Madeira R.
    Hashemi, S. M. S.
    Paats, M. S.
    Monkhorst, K.
    Heideman, D. A. M.
    Groves, M.
    Radonic, T.
    Smit, E. F.
    Schuuring, E.
    van der Wekken, A. J.
    de Langen, A. J.
    LUNG CANCER, 2020, 141 : 9 - 13
  • [35] A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer
    Yasuda, Hiroyuki
    Ichihara, Eiki
    Sakakibara-Konishi, Jun
    Zenke, Yoshitaka
    Takeuchi, Shinji
    Morise, Masahiro
    Hotta, Katsuyuki
    Sato, Mineyoshi
    Matsumoto, Shingo
    Tanimoto, Azusa
    Matsuzawa, Reiko
    Kiura, Katuyuki
    Takashima, Yuta
    Yano, Seiji
    Koyama, Junji
    Fukushima, Takahiro
    Hamamoto, Junko
    Terai, Hideki
    Ikemura, Shinnosuke
    Takemura, Ryo
    Goto, Koichi
    Soejima, Kenzo
    LUNG CANCER, 2021, 162 : 140 - 146
  • [36] A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer
    Hu, Song
    Ming, Hao
    He, Qian
    Ding, Ming
    Ding, Hao
    Li, Chong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [37] Amivantamab in Post-platinum EGFR Exon 20 Insertion Mutant Non-small Cell Lung Cancer
    Sabari, J. K.
    Shu, C. A.
    Park, K.
    Leighl, N.
    Mitchell, P.
    Kim, S.
    Lee, J.
    Kim, D.
    Viteri, S.
    Spira, A.
    Han, J.
    Trigo, J.
    Lee, C. K.
    Lee, K. H.
    Girard, N.
    Yang, T.
    Goto, K.
    Sanborn, R. E.
    Yang, J. C.
    Xie, J.
    Roshak, A.
    Thayu, M.
    Knoblauch, R. E.
    Cho, B. C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S108 - S109
  • [38] Epidemiological characteristics and therapeutic advances of EGFR exon 20 insertion mutations in non-small cell lung cancer
    Pan, Binyang
    Liang, Jiaqi
    Shi, Haochun
    Rao, Kungeng
    Guo, Weigang
    Zhan, Cheng
    THORACIC CANCER, 2023, 14 (33) : 3247 - 3258
  • [39] The landscape of EGFR exon 20 insertion mutations in Chinese patients with non-small cell lung cancer.
    Xu, Shun
    Fu, Zhichao
    CANCER RESEARCH, 2022, 82 (12)
  • [40] Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea
    Byeon, Seonggyu
    Kim, Youjin
    Lim, Sung Won
    Cho, Jang Ho
    Park, Sehoon
    Lee, Jiyun
    Sun, Jong-Mu
    Choi, Yoon-La
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    CANCER RESEARCH AND TREATMENT, 2019, 51 (02): : 623 - 631
12345